Ayala Pharmaceuticals Inc (ADXS)

[James salmon]

The way I see the rest of the year going.

Now if all plays out we have potential for the following;

Phase 3 start
SITC abstract announcement.
EU approval - certainly possible as per presentation,
IND filing for NEO.
SITC - presentation for combo results
Canine vaccine approval.

All above could and I believe will occur over the next 3 1/2 months.

If all plays out as I believe most will and results will be positive, share price will be way above where it is now, and probably reason why Fidelity wanted in after Amgen deal.